{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:11:48Z","timestamp":1787969508898,"version":"build-2784847793"},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["eJHaem"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Healthcare is shifting from a disease\u2010centered to patient\u2010centered approach, and aspects of health such as quality of life (QoL) are becoming increasingly relevant. \u201cE\u2010Res Salud\u201d for hematological malignancies is a value\u2010based healthcare program aiming to improve patient experience and outcomes. The program collects e\u2010PROMs via automatically deployed, validated questionnaires over a mobile application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicenter prospective observational cohort study including 243 patients with Hodgkin and non\u2010Hodgkin lymphoma receiving outpatient intravenous immunochemotherapy at four teaching hospitals in Madrid, Spain, of whom 121 participated in the \u201cE\u2010Res Salud\u201d program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that adverse event reporting differs significantly between patients and healthcare professionals. Participants showed significantly lower rates of emergency department visits (37.2%\u00a0vs. 56.6%;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.01) and unplanned hospital admissions (21.5%\u00a0vs. 32.8%;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.05), as well as significantly higher rates of treatment completion and overall survival (88.4%\u00a0vs. 79.5% after 18 months of follow\u2010up; stratified hazard ratio, 2.30; 95% CI 1.25\u20134.22;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An e\u2010PROMS program for patients with lymphoma is associated with lower use of healthcare and improved clinical outcomes. Patients and hematologists report adverse events differently, demonstrating the importance of patient\u2010reported outcome measurement to improve symptom management in clinical practice.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial Registration<\/jats:bold>\n                      : The authors have confirmed clinical trial registration is not needed for this submission\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jha2.70129","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:15:46Z","timestamp":1756894546000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of an Electronic Patient Reported Outcome Measures (e\u2010PROMs) Program on Symptom Reporting, Use of Healthcare, and Overall Survival in Patients With Lymphoma: A Multicenter Prospective Study"],"prefix":"10.1002","volume":"6","author":[{"given":"Ra\u00fal","family":"C\u00f3rdoba","sequence":"first","affiliation":[{"name":"Haematology Department Hospital Universitario Fundacion Jimenez Diaz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"del Olmo Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Hospital Management Quir\u00f3nsalud 4\u2010H Network  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ramos","sequence":"additional","affiliation":[{"name":"Haematology Department Hospital Universitario Fundacion Jimenez Diaz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"L\u00f3pez Garc\u00eda","sequence":"additional","affiliation":[{"name":"Haematology Department Hospital Universitario Fundacion Jimenez Diaz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Morillo","sequence":"additional","affiliation":[{"name":"Haematology Department Hospital Universitario Fundacion Jimenez Diaz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria\u2010Angeles","family":"P\u00e9rez\u2010S\u00e1enz","sequence":"additional","affiliation":[{"name":"Haematology Department Hospital Universitario Fundacion Jimenez Diaz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Miranda","sequence":"additional","affiliation":[{"name":"Haematology Department Hospital Universitario Rey Juan Carlos  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Martos","sequence":"additional","affiliation":[{"name":"Hematology Hospital Universitario General de Villalba  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Beltr\u00e1n","sequence":"additional","affiliation":[{"name":"Hematology Department Hospital Universitario Infanta Elena  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Castillo","sequence":"additional","affiliation":[{"name":"Pharmacy Department Hospital Universitario Fundacion Jimenez Diaz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Herrero","sequence":"additional","affiliation":[{"name":"Information Technology and Systems Department Quir\u00f3nsalud 4\u2010H Network  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"G\u00f3mez\u2010Meana","sequence":"additional","affiliation":[{"name":"Information Technology and Systems Department Quir\u00f3nsalud 4\u2010H Network  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0317-2778","authenticated-orcid":false,"given":"Bernadette","family":"Pfang","sequence":"additional","affiliation":[{"name":"Pharmacy Department Hospital Universitario Fundacion Jimenez Diaz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Short Apellaniz","sequence":"additional","affiliation":[{"name":"Hospital Management Quir\u00f3nsalud 4\u2010H Network  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Arcos\u2010Campillo","sequence":"additional","affiliation":[{"name":"Hospital Management Hospital Universitario Fundacion Jimenez Diaz  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/S11764\u2010022\u201001216\u2010W"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD\u20102017\u201003\u2010737403"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/CNCR.31928"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJCA.2023.01.005"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.CCT.2022.106882"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2016.1181815"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/S00520\u2010021\u201006052\u20109"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/CAT.22.0414"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.9334"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.14694\/EDBOOK_AM.2014.34.161"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.ANNONC.2022.04.007"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/CAT.23.0083"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/JNCI\/DJU244"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1634\/THEONCOLOGIST.2019\u20100355"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.5694\/MJA2.50893"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/HON.2522"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.0830"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(09)70200\u20101"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.3324\/HAEMATOL.2021.280413"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2024.1353101"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/BJD.12644"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1515\/SJPAIN\u20102021\u20100162\/ASSET\/GRAPHIC\/J_SJPAIN\u20102021\u20100162_FIG_008.JPG"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000973644.98699.04"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2024.1353101\/BIBTEX"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/CURRONCOL32050265\/S1"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114313"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD\u20102022\u2010159076"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANETWORKOPEN.2024.14425"},{"key":"e_1_2_11_30_1","unstructured":"The European Hematology Association (EHA) \u201cGuidelines for the Use and Reporting of Patient\u2010Reported Outcomes in Multiple Myeloma Clinical Trials \u201d accessed July 12 2025 https:\/\/ehaweb.org\/clinical\u2010practice\/guidelines\u2010by\u2010areas\u2010of\u2010disease\/guidelines\u2010for\u2010the\u2010use\u2010and\u2010reporting\u2010of\u2010patient\u2010reported\u2010outcomes\u2010in\u2010multiple\u2010myeloma\u2010clinical\u2010trials."},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.2196\/27886"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/S41687\u2010021\u201000373\u20103"}],"container-title":["eJHaem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jha2.70129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:53:33Z","timestamp":1761389613000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jha2.70129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1002\/jha2.70129"],"URL":"https:\/\/doi.org\/10.1002\/jha2.70129","archive":["Portico"],"relation":{},"ISSN":["2688-6146","2688-6146"],"issn-type":[{"value":"2688-6146","type":"print"},{"value":"2688-6146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"2025-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70129"}}